Noribogaine Purification via Solid Support Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing noribogaine from ibogaine fail to produce a composition that is substantially free of ibogaine contamination, with existing patents lacking clear methods for achieving high purity and enantiomeric enrichment of noribogaine.
Innovation Solution
The development of noribogaine compositions that are at least 95% of the 2(R), 4(S), 5(S), 6(S), and 18(R) enantiomer, with less than 0.5% ibogaine contamination, using solid support synthesis and specific purification methods such as O-demethylation with boron tribromide and subsequent attachment to a cleavable linker on a solid support, allowing for repeated washing and cleavage to achieve high purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional O-demethylation methods are used to prepare noribogaine from ibogaine, then noribogaine can be produced, but the composition contains unacceptable levels of ibogaine contamination (greater than 0.5 wt%)
Solution Approach 1:
The patent segments the noribogaine synthesis process into distinct stages: (1) O-demethylation of ibogaine to produce noribogaine, (2) attachment of the hydroxyl group to a solid support via cleavable linker, (3) repeated washing to remove ibogaine contamination, and (4) cleavage to release purified noribogaine. This segmentation allows selective removal of ibogaine at the washing stage while retaining noribogaine on the solid support, achieving greater than 99.5% purity with less than 0.5 wt% ibogaine contamination.
Solution Approach 2:
The patent introduces a solid support with a cleavable linker as an intermediary carrier for noribogaine during purification. The hydroxyl group of noribogaine attaches to the solid support, allowing the molecule to be retained on the support while soluble ibogaine contamination is washed away. The cleavable linker then enables release of the purified noribogaine from the solid support, achieving separation of noribogaine from ibogaine impurities.
2Manufacturing precision
If conventional purification methods are used, then noribogaine can be isolated, but enantiomeric enrichment is not achieved (less than 95% of the desired enantiomer)
Solution Approach 1:
The patent performs preliminary enantiomeric enrichment during the O-demethylation step itself by using chiral conditions or starting materials that favor formation of the desired 2(R), 4(S), 5(S), 6(S), and 18(R) enantiomer. This preliminary action ensures that the noribogaine produced is already enantiomerically enriched before the solid support purification step, eliminating the need for additional complex chiral resolution steps.
3Manufacturing precision
If repeated washing and cleavage steps are performed on solid support, then ibogaine contamination is reduced to less than 0.5 wt%, but the process time increases
Solution Approach 1:
The patent implements continuous washing of the solid support-bound noribogaine with fresh solvent to repeatedly remove ibogaine contamination without interrupting the overall process. The solid support remains in place while multiple washing cycles are performed, maintaining continuous purification action. This is followed by a single cleavage step to release the highly purified noribogaine, achieving greater than 99.5% purity efficiently.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in noribogaine compositions that are exceptionally pure and enantiomerically enriched, significantly reducing ibogaine contamination to less than 0.1% by weight, making them suitable for treating addiction and pain without the hallucinogenic effects of ibogaine.
Implementation Method 1
Demethylation may be accomplished by conventional techniques such as by reaction with boron tribromide/methylene chloride at room temperature
Implementation Method 2
subsequent attachment to a cleavable linker on a solid support, allowing for repeated washing and cleavage to achieve high purity
Data Source
AI summary
Disclosed are noribogaine compositions comprising a very high level of the 2(R), 4(S), 5(S), 6(S) and 18(R) enantiomer and not more than 0.5 wt % of ibogaine relative to the total amount of noribogaine.